Cargando…

Mucormycosis and COVID-19 an epidemic in a pandemic?

Mucormycosis and aspergillosis are rare, invasive and life-threatening infections primarily caused by Rhizopus arrhizus and Aspergillus fumigatus with higher case fatality rates (>50%), respectively. Invasive Aspergillosis and Mucormycosis have been established and recognized as complications of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banerjee, Indrajit, Robinson, Jared, Asim, Mohammad, Sathian, Brijesh, Banerjee, Indraneel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Nepal Epidemiological Association 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266401/ https://www.ncbi.nlm.nih.gov/pubmed/34290893 http://dx.doi.org/10.3126/nje.v11i2.37342

Ejemplares similares

Omicron: The pandemic propagator and lockdown instigator – what can be learnt from South Africa and such discoveries in future
por: Banerjee, Indrajit, et al.
Publicado: (2021)

A contemporary insight of metabolomics approach for COVID-19: Potential for novel therapeutic and diagnostic targets
por: Asim, Mohammad, et al.
Publicado: (2020)

Post COVID syndrome: A novel challenge and threat to international health
por: Banerjee, Indrajit, et al.
Publicado: (2022)

COVID-19 pandemic and suicides in Nepal: Way forward for prevention
por: Banerjee, Indrajit, et al.
Publicado: (2021)

COVID-19 and mutations a threat level assessment
por: Robinson, Jared, et al.
Publicado: (2021)

COVID-19: Are reinfections a global health threat?
por: Banerjee, Indrajit, et al.
Publicado: (2021)

COVID-19 vaccines and immunization in the paediatric population
por: Banerjee, Indrajit, et al.
Publicado: (2022)

COVID-19 and Artificial Intelligence: the pandemic pacifier
por: Banerjee, Indrajit, et al.
Publicado: (2020)

Corticosteroid induced avascular necrosis and COVID-19: The drug dilemma
por: Banerjee, Indrajit, et al.
Publicado: (2021)

Treatment of Long COVID or Post COVID syndrome: A Pharmacological approach
por: Banerjee, Indrajit, et al.
Publicado: (2022)

South Africa and its COVID-19 prohibition predilection
por: Banerjee, Indrajit, et al.
Publicado: (2020)

Global re-emergence of human monkeypox: Population on high alert
por: Banerjee, Indrajit, et al.
Publicado: (2022)

Dengue Dilemma in Nepal
por: Banerjee, Indrajit, et al.
Publicado: (2022)

The Growing Importance of Mixed-Methods Research in Health
por: Wasti, Sharada Prasad, et al.
Publicado: (2022)

Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic
por: Bhanuprasad, Kundakarla, et al.
Publicado: (2021)

COVID-19: Lockdown and its impact on medical students: A cross sectional study from a medical school in Mauritius
por: Banerjee, Indrajit, et al.
Publicado: (2021)

Socio demographic profile and utilization pattern of antipsychotic drugs among schizophrenic inpatients: a cross sectional study from western region of Nepal
por: Banerjee, Indrajit, et al.
Publicado: (2013)

The Promising Future for Complex Innovative Trial Design in Clinical Research
por: Sathian, Brijesh, et al.
Publicado: (2023)

COVID-19 in Qatar: Ways forward in public health and treatment
por: van Teijlingen, Edwin, et al.
Publicado: (2021)

Mucormycosis in COVID-19 pandemic: Risk factors and linkages
por: Kumar, Manoj, et al.
Publicado: (2021)

Self-medication practice among preclinical university students in a medical school from the city of Pokhara, Nepal
por: Banerjee, Indrajit, et al.
Publicado: (2016)

Is Robotics the real game changer for Urological cancer care during COVID-19 crisis?
por: Banerjee, Indraneel, et al.
Publicado: (2021)

The Art of the Editorial
por: van Teijlingen, Edwin R., et al.
Publicado: (2022)

Post-Traumatic Stress Disorder among the Flood Affected Population in Indian Subcontinent
por: Asim, Mohammad, et al.
Publicado: (2019)

Impact of COVID-19 on clinical trials and clinical research: A systematic review
por: Sathian, Brijesh, et al.
Publicado: (2020)

COVID-19 and Mucormycosis: A Black Fungus Disaster?
por: Chillana, Suchira, et al.
Publicado: (2022)

Nipah virus (NiV): a ‘new’ addition to the ever changing landscape of infections
por: James, Sruthi, et al.
Publicado: (2018)

Mucormycosis: An Epidemic Complicating the COVID-19 Pandemic
por: Khade, Shalaka, et al.
Publicado: (2023)

COVID-19 airborne transmission: a new frontier of infection
por: Banerjee, Indrajit, et al.
Publicado: (2021)

Guidance to applying for health research grants in the UK
por: Sathian, Brijesh, et al.
Publicado: (2022)

Mucormycosis (black fungus) infection and misuse of corticosteroids in COVID 19 patients in Syria
por: Mohsen, Aya Yaser, et al.
Publicado: (2022)

Increase in mucormycosis hospitalizations in southeastern Brazil during the COVID-19 pandemic: a 2010-2021 time series
por: dos Santos, Ivan Lira, et al.
Publicado: (2023)

COVID-19-Associated Pulmonary Mucormycosis: An Underdiagnosed Entity with High Mortality
por: Muthu, Valliappan, et al.
Publicado: (2022)

COVID-19 Pandemic: Public Health Implications in Nepal
por: Asim, Mohammad, et al.
Publicado: (2020)

Rhino-orbital Mucormycosis in a COVID-19 Patient: The First Case in Malaysia
por: Chang, Chee Yik, et al.
Publicado: (2022)

Incidence of COVID-19-Associated Mucormycosis in COVID-19 Patients after Discharge from the COVID-19 Hospital
por: Kulshrestha, Aayush, et al.
Publicado: (2023)

Epidemic of Mucormycosis in COVID-19 Pandemic: A Position Paper
por: Kulkarni, Rahul, et al.
Publicado: (2022)

Revisiting ‘The Plague’ by Camus: Shaping the ‘social absurdity’ of the COVID-19 Pandemic
por: Banerjee, Debanjan, et al.
Publicado: (2020)

Coronavirus Disease (COVID-19) and the risk of Post-Traumatic Stress Disorder: A mental health concern in Nepal
por: Asim, Mohammad, et al.
Publicado: (2020)

Mucormycosis in post-covid patients: An epidemic in pandemic
por: Kesarwani, Vasudha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5umlpb1hc9i085vltqe3asg78b